More News

03 Dec 2019 Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics
02 Dec 2019 Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy
02 Dec 2019 Samyang Biopharm USA, Inc and CanCure LLC Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic
27 Nov 2019 Hoth Therapeutics and North Carolina State University Enter License Agreement for Gene Therapy
26 Nov 2019 Woolsey Pharmaceuticals Signs License Agreement With Asahi Kasei Pharma for Exclusive Rights to Fasudil
25 Nov 2019 Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis
25 Nov 2019 Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death
21 Nov 2019 Vor Biopharma and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Hematopoietic Stem Cells (eHSCs) to Treat Cancer
21 Nov 2019 ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational “bNAb” with potential for long-acting HIV treatment and prevention
21 Nov 2019 Harpoon Therapeutics and AbbVie Announce Licensing and Option Collaboration to Advance HPN217, Harpoon’s BCMA-Targeting TriTAC®, and Expand Existing Discovery Collaboration
21 Nov 2019 Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
20 Nov 2019 Excelra Announces a Drug Repurposing Collaboration With Maruho On Dermatological Applications
20 Nov 2019 Dragonfly Therapeutics Announces Collaboration with AbbVie for Autoimmune Diseases and Oncology
19 Nov 2019 Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants
19 Nov 2019 Zelluna Immunotherapy and Glycostem Therapeutics announce partnership to develop allogeneic TCR-NK therapies
19 Nov 2019 Idorsia enters into a collaboration with Antares for the development of a novel self-administered drug-device product for selatogrel
19 Nov 2019 Alkermes to Acquire Rodin Therapeutics
19 Nov 2019 Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-Related Cardio-Metabolic Diseases
16 Nov 2019 Promedior Enters Into Definitive Merger Agreement To Be Acquired By Roche
14 Nov 2019 Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies
14 Nov 2019 Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseases
14 Nov 2019 Poised for Significant Growth and Profitability, BioMarin Shares Company Highlights During R&D Day on November 14th in New York
14 Nov 2019 Takeda Announces 12 New Molecular Entities with the Potential for 14 Launches in the Next Five Years at 2019 R&D Day
14 Nov 2019 Exicure and Allergan Enter Into Collaboration, Option and License Agreement to Discover and Develop SNA-based Treatments for Hair Loss Disorders
13 Nov 2019 Avidity Biosciences Completes $100 Million Series C Financing

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up